147 related articles for article (PubMed ID: 32165088)
1. Acute visual loss caused by transient choroid ischemia and subretinal hyperreflective material after photodynamic therapy.
Chen YC; Chen SN; Chuang CC
J Formos Med Assoc; 2020 Sep; 119(9):1448-1449. PubMed ID: 32165088
[No Abstract] [Full Text] [Related]
2. Improvement of visual acuity after photodynamic therapy for choroidal neovascularization in choroidal osteoma.
Blaise P; Duchateau E; Comhaire Y; Rakic JM
Acta Ophthalmol Scand; 2005 Aug; 83(4):515-6. PubMed ID: 16029286
[No Abstract] [Full Text] [Related]
3. Acute severe visual decrease after photodynamic therapy with verteporfin: spectral-domain OCT features.
Keane PA; Aghaian E; Ouyang Y; Chong LP; Sadda SR
Ophthalmic Surg Lasers Imaging; 2010; 41 Suppl():S85-8. PubMed ID: 21117609
[TBL] [Abstract][Full Text] [Related]
4. ONE-YEAR RESULTS OF ADJUNCTIVE PHOTODYNAMIC THERAPY FOR TYPE 1 NEOVASCULARIZATION ASSOCIATED WITH THICKENED CHOROID.
Lee JH; Lee WK
Retina; 2016 May; 36(5):889-95. PubMed ID: 27115853
[TBL] [Abstract][Full Text] [Related]
5. Choroidal nonperfusion with significant subretinal exudation after PDT of predominantly classic CNV: an OCT and FFA study.
Jalil A; Mercieca K; Chaudhry NL; Stanga PE
Eur J Ophthalmol; 2009; 19(3):490-3. PubMed ID: 19396803
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
7. [Subjective decrease of visual acuity after photodynamic therapy: documentation by optical coherence tomography and its correlation with visual acuity].
Mennel S; Callizo J; Meyer CH; Kroll P
Arch Soc Esp Oftalmol; 2005 Jul; 80(7):413-6. PubMed ID: 16059818
[TBL] [Abstract][Full Text] [Related]
8. Retinal and choroidal alterations following photodynamic therapy.
Durlu YK
Adv Exp Med Biol; 2003; 533():115-22. PubMed ID: 15180255
[No Abstract] [Full Text] [Related]
9. Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma.
Shields CL; Sun H; Demirci H; Shields JA
Arch Ophthalmol; 2005 Dec; 123(12):1658-66. PubMed ID: 16344436
[TBL] [Abstract][Full Text] [Related]
10. Circulatory changes in the choroidal vasculature after verteporfin-based photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
Isola V; Pece A; Brancato R
Retina; 2004 Aug; 24(4):618-20. PubMed ID: 15300088
[No Abstract] [Full Text] [Related]
11. Outcomes of anti-vascular endothelial growth factor therapy in the management of choroidal neovascularization associated with choroidal osteoma.
Khan MA; DeCroos FC; Storey PP; Shields JA; Garg SJ; Shields CL
Retina; 2014 Sep; 34(9):1750-6. PubMed ID: 24936941
[TBL] [Abstract][Full Text] [Related]
12. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.
Parodi MB; Iacono P; Papayannis A; Sheth S; Bandello F
Arch Ophthalmol; 2010 Apr; 128(4):437-42. PubMed ID: 20142520
[TBL] [Abstract][Full Text] [Related]
13. Characteristic spectral-domain optical coherence tomography findings of multifocal choroiditis.
Vance SK; Khan S; Klancnik JM; Freund KB
Retina; 2011 Apr; 31(4):717-23. PubMed ID: 21386760
[TBL] [Abstract][Full Text] [Related]
14. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
Lee H; Ji B; Chung H; Kim HC
Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
[TBL] [Abstract][Full Text] [Related]
15. A 24-year-old woman with sudden-onset, unilateral vision loss.
Khalili P; Adib NE; Jafari HK; Shamsi R; Dehghani S
Digit J Ophthalmol; 2019 Apr; 25(4):72-78. PubMed ID: 32076392
[No Abstract] [Full Text] [Related]
16. Multimodal imaging of choroidal macrovessel.
Lima LH; Pimenta R; Zett C
J Fr Ophtalmol; 2020 Apr; 43(4):371-372. PubMed ID: 32093959
[No Abstract] [Full Text] [Related]
17. Comparison of clinical features and 3-month treatment response among three different choroidal thickness groups in polypoidal choroidal vasculopathy.
Kong M; Kim SM; Ham DI
PLoS One; 2017; 12(9):e0184058. PubMed ID: 28886052
[TBL] [Abstract][Full Text] [Related]
18. Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography.
Tamura H; Tsujikawa A; Otani A; Gotoh N; Sasahara M; Kameda T; Iwama D; Yodoi Y; Mandai M; Yoshimura N
Br J Ophthalmol; 2007 Sep; 91(9):1152-9. PubMed ID: 17314148
[TBL] [Abstract][Full Text] [Related]
19. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
[TBL] [Abstract][Full Text] [Related]
20. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
